EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications

Gianmarco Bertoni iD, Sara Ristori iD, Daniela Monti iD

Cells · 2026

DOI: 10.3390/cells15080657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Gianmarco Bertoni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Immunosenescence, Inflammation, Aging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 327 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Next Generation EU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is accompanied by profound alterations in immune function, termed immunosenescence, and by a chronic, low-grade inflammatory state known as inflammaging. These processes are increasingly recognized as central drivers of age-related neurodegenerative diseases, including Alzheimer’s Disease, Parkinson’s Disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis. In the central nervous system, senescent microglia and astrocytes lose their homeostatic and neuroprotective functions, while systemic immune aging and blood–brain barrier dysfunction further amplify neuroinflammation and impair protein aggregate clearance. This sustained pro-inflammatory environment promotes synaptic dysfunction, neuronal loss and cognitive decline. Here, we synthesize current knowledge of the mechanistic links among immunosenescence, inflammaging, and neurodegeneration, highlighting innate and adaptive immune dysregulation, mitochondrial impairment, and failed resolution pathways. We further discuss emerging therapeutic strategies, including senolytics, immunoceuticals, microbiome-based interventions and advanced drug delivery systems, aimed at restoring immune homeostasis and enhancing brain resilience. By integrating mechanistic and translational insights, this review provides a framework for developing novel interventions to target immune aging in neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesImmunosenescenceInflammationAgingNeuroimmunomodulationHumansAnimals

Stichwörter der Autor:innen

aginggeroscienceimmunomodulationimmunosenescenceinflammagingneurodegenerative diseasesneuroinflammationsenolyticstherapeutic strategies

Autor:innen und Institutionen

  • Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, 50134 Florence, Italy.

ORCID-Profile: Gianmarco Bertoni, Sara Ristori, Daniela Monti

Förderung

  • Next Generation EU

Zitieren

APA

Bertoni, G., Ristori, S., & Monti, D. (2026). Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells. https://doi.org/10.3390/cells15080657

Vancouver

Bertoni G, Ristori S, Monti D. Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications. Cells. 2026. doi:10.3390/cells15080657

BibTeX
@article{Bertoni2026,
  author = {Bertoni, Gianmarco and Ristori, Sara and Monti, Daniela},
  title = {Immunosenescence and Inflammaging as Drivers of Neurodegeneration: Cellular Mechanisms, Neuroimmune Crosstalk, and Therapeutic Implications},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15080657}
}
Kostenlos starten →